Skip to content

Evaluation of the TRANSEND Program

Non-randomized Experimental Study Evaluating the Impact of Implantation of a New Organization in the Adult Sector Intended to Improve the Transition of Young People With Endocrine or Metabolic Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04277286
Acronym
EVATRANSEND
Enrollment
202
Registered
2020-02-20
Start date
2020-09-09
Completion date
2020-10-10
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Patient Transfer to Adult Service:Transition Program

Brief summary

Transend is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital. The main objective of the study is to compare the rate of patients lost to follow-up at 24 months after the transfer of pediatrics between the Transend group and the (historical) control group.

Detailed description

Adolescence and early adulthood represent important periods for young people suffering from chronic diseases. Several observational studies show needs not covered by care services at this period and significant lost to follow-up rates. Transend is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital (Paris, France). Since September 1, 2016, approximately 500 patients benefited from it.

Interventions

BEHAVIORALsurvey

Behavioral study of patients who are in the Transend Program (compliance in follow-up visits after transfert from pediatric to adult care in the 24 months)

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 32 Years
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 to 32 * Patient with endocrine or metabolic disease * Patient who had a follow-up in a pediatric department for his endocrine or metabolic disease * Patient transferred to the adult sector in the endocrinology, metabolism or nutrition department of Pitié-Salpêtrière * Patient who had a first post-transfer consultation between January 1, 2015 and September 1, 2017 * Patient with a social security protection

Exclusion criteria

* Patient who transferred to another adult service before being followed at Pitié-Salpêtrière * Patient who has expressed his opposition to participate in this research

Design outcomes

Primary

MeasureTime frameDescription
Rate of patients lost to follow-up at 24 months post transfert24 months post transfertDefined by pathology as patients who have not been seen in a medical consultation since a time superior of the recommendation for his state of Heath at 24 months post-transfer and for whom no elements confirm a next consultation in the center nor a follow-up in another center

Secondary

MeasureTime frameDescription
Relationship of trust between caregiver and patient24 to 36 months post transfertScore calculated by wake Forest scaleis a validated scale of 10 items for the evaluation of the different components of trust.including 3 items on loyalty, 3 items on competence, 1 item on honesty and 3 items on global trust. (short version) resulting from an evaluation anonymously made by patients
Time to first consultation in adult medicine24 to 36 months post transfertExperimental group: patients transferred to adult service according to the Transend transition program (between September 2016 and January 2018) Control group: patients transferred to adult service without a transition program, in the same center, before the implementation of Traansend (between January 2015 and September 2016)
Patient satisfaction24 to 36 months post transfetSatisfaction collected on a scale of 0 to 10 where 0 means the worst transfer imaginable resulting an anonymous assessment carried out by the Patients
Number of consultations not honored by the patient24 to 36 months post transfertExperimental group: patients transferred to adult service according to the Transend transition program (between September 2016 and January 2018) Control group: patients transferred to adult service without a transition program, in the same center, before the implementation of Traansend (between January 2015 and September 2016)
Compare the experience of the transition betmeen the two Groups24 to 36 months post transfretFrequency of feeling broken, continuity, need to contact the paediatrician, attention and perceived availability on the part of professionals on arrival in the adult hospital
Assess Transend's efficiency24 to 36 months post transfretCost/incremental cost-effectiveness ratio in cost gained and cost per loss of view
Avoided care consumption and associated costs24 to 36 months post transfretCosts associated with hospital emergency room visits, home visit of SOS doctor, unplanned hospitalization

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026